- Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy AdultsCondition: Pneumococcal Vaccines
Interventions: Other: normal saline injection; Biological: SPWCV + alum
Sponsors: Program for Appropriate Technology in Health; PATH Vaccine Solutions
Recruiting - verified February 2012 - Conditions: Staphylococcal Infections; Yeast Infections; Candidiasis
Interventions: Biological: NDV-3 vaccine with alum administered IM; Biological: NDV-3 vaccine without alum administered IM; Biological: Placebo administered ID; Biological: NDV-3 vaccine without alum administered ID
Sponsors: NovaDigm Therapeutics, Inc.; NovaDigm Therapeutics, Inc.; Department of Defense
Recruiting - verified October 2011 - Conditions: Malaria; Malaria Vaccines; Plasmodium Falciparum Malaria
Intervention: Biological: Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified March 2011 - Condition: Healthy
Intervention: Biological: RiVax
Sponsors: FDA Office of Orphan Products Development; FDA Office of Orphan Products Development
Recruiting - verified July 2011
 |
Aluminum Sulfate Clinical Trials |
